ERJ Open Research, 2024 SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trial Long M., Abo-Leyah H., Giam Y. et al. Olink Target 48Infectious DiseasesPathophysiologySerum | | | | |
iScience, 2024 Epigenetic, transcriptional, and functional characterization of myeloid cells in familial Mediterranean fever Röring R., Li W., Liu R. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasmaCell Culture Supernatant | | | | |
The Journal of Infectious Diseases, 2024 Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19 Strunz B., Maucourant C., Mehta A. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologySerum | | | | |
Science Translational Medicine, 2024 APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model Jiang, S., Li et al. Olink Target 96 MouseNeurologyPathophysiologyMouse Tissue Lysate | | | | |
The Journal of Clinical Endocrinology & Metabolism, 2024 Magnesium Supplementation Modulates T-cell Function in People with Type 2 Diabetes and Low Serum Magnesium Levels Drenthen L., Ajie M., de Baaij J. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Cell Genomics, 2024 Genetic associations with ratios between protein levels detect new pQTLs and reveal protein-protein interactions Suhre K. Olink Explore 3072/384Wider Proteomics StudiesData SciencePlasma | | | | |
ESC Heart Failure, 2024 Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement Beuthner B., Elkenani M., Evert K. et al. Olink Target 96CVDPathophysiologySerum | | | | |
Translational Oncology, 2024 CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC Salvermoser L., Goldberg S., Alunni-Fabbroni M. et al. Olink Target 96OncologyPathophysiologyPatient StratificationPlasma | | | | |
Journal of Clinical Periodontology, 2024 LIGHT protein: A novel gingival crevicular fluid biomarker associated with increased probing depth after periodontal surgery Esberg A., Kindstedt E., Isehed C. et al. Olink Target 96Other Diseases & SyndromesPatient StratificationGingival Crevicular Fluid | | | | |
Journal of Clinical Immunology, 2024 Thymic Atrophy and Immune Dysregulation in Infants with Complex Congenital Heart Disease Bremer S., Boxnick A., Glau L. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
International Journal of Cancer, 2024 Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis Meng C., Sun L., Shi J. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
World Journal of Urology, 2024 Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy Guldvik I., Ramberg H., Kristensen G. et al. Olink Target 96OncologyPatient StratificationSerum | | | | |
Arteriosclerosis, Thrombosis, and Vascular Biology, 2024 Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia Lindley K., Perry A., Jacobs M. et al. Olink Explore 3072/384ObstetricsPathophysiologyPatient StratificationPlasma | | | | |
Frontiers in Immunology, 2024 Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy Guo H., Wang T., Yu J. et al. Olink Target 96OphthalmologyPatient StratificationVitreous | | | | |
Frontiers in Immunology, 2024 Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19 Baranova A., Luo J., Fu L. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Communications, 2024 Converging and evolving immuno-genomic routes toward immune escape in breast cancer Blanco-Heredia J., Souza C., Trincado J. et al. Olink Target 96OncologyPathophysiologyPlasmaSerumTissue Lysate | | | | |
Molecular Cancer, 2024 Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide Toulmonde M., Guegan J., Spalato-Ceruso M. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Acta Biomaterialia, 2024 Increased matrix stiffness enhances pro-tumorigenic traits in a physiologically relevant breast tissue- monocyte 3D model Abrahamsson A., Boroojeni F., Naeimipour S. et al. Olink Target 96OncologyTechnical EvaluationMicrodialysis Fluid | | | | |
Annals of the Rheumatic Diseases, 2024 Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker Ea H., Kischkel B., Chirayath T. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Dermatology and Therapy, 2024 Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Ludbrook V., Budd D., Thorn K. et al. Olink Target 96Dermatological DiseasesPathophysiologyPlasma | | | | |